$71.48
-0.33-0.46%
Pre-Market: 5:37 PM EDT
Comments
Loading...
Sarepta Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:SRPT | Benzinga
Sarepta Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Apr 30
EPS Estimate
$1.760
Quarterly Revenue Estimate
$709.75M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.90B
Analyze the earnings history of Sarepta Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics | $0.73 | $1.76 | — | — | $413.46M | $709.75M | — | — | 04/30/2025 | Get Alert |
| SRPT | Sarepta Therapeutics | $0.82 | $1.90 | $1.90 | 0.00% | $396.78M | $627.58M | $658.41M | 4.91% | 02/26/2025 | Get Alert |
| SRPT | Sarepta Therapeutics | $0.31 | $0.37 | $0.62 | 67.57% | $331.82M | $409.30M | $467.17M | 14.14% | 11/06/2024 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.85 | $0.02 | $0.44 | 2100.00% | $261.24M | $396.26M | $362.93M | -8.41% | 08/07/2024 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.99 | -$0.07 | $0.73 | 1142.86% | $253.50M | $373.28M | $413.46M | 10.77% | 05/01/2024 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.53 | $0.01 | $0.82 | 8100.00% | $258.43M | $385.81M | $396.78M | 2.84% | 02/28/2024 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.80 | -$1.32 | $0.37 | 128.03% | $230.27M | $288.50M | $331.82M | 15.01% | 11/01/2023 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.18 | -$1.89 | -$0.85 | 55.03% | $233.49M | $264.45M | $261.24M | -1.21% | 08/02/2023 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.56 | -$1.38 | -$0.97 | 29.71% | $210.83M | $241.96M | $253.50M | 4.77% | 05/02/2023 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.77 | -$1.35 | -$0.53 | 60.74% | $201.46M | $248.34M | $258.43M | 4.06% | 02/28/2023 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.19 | -$1.43 | -$0.80 | 44.06% | $189.41M | $234.52M | $230.27M | -1.81% | 11/02/2022 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.52 | -$1.18 | -$1.18 | 0.00% | $164.09M | $220.81M | $233.49M | 5.74% | 08/02/2022 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.54 | -$1.27 | -$0.56 | 55.91% | $146.93M | $206.44M | $210.83M | 2.13% | 05/04/2022 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.84 | -$1.13 | -$0.77 | 31.86% | $145.14M | $198.61M | $201.46M | 1.44% | 03/01/2022 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.42 | -$1.89 | -$0.19 | 89.95% | $143.92M | $173.42M | $189.41M | 9.22% | 11/03/2021 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.51 | -$1.29 | -$1.52 | -17.83% | $137.36M | $162.64M | $164.09M | 0.89% | 08/04/2021 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.04 | -$1.78 | -$1.54 | 13.48% | $113.67M | $143.33M | $146.93M | 2.51% | 05/05/2021 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.57 | -$1.77 | -$1.84 | -3.95% | $100.11M | $146.29M | $145.14M | -0.79% | 03/01/2021 | Get Alert |
| SRPT | Sarepta Therapeutics | -$1.14 | -$1.71 | -$1.42 | 16.96% | $99.04M | $137.43M | $143.92M | 4.73% | 11/05/2020 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.83 | -$1.72 | -$1.51 | 12.21% | $94.67M | $118.78M | $137.36M | 15.64% | 08/05/2020 | Get Alert |
| SRPT | Sarepta Therapeutics | -$0.75 | -$1.78 | -$1.04 | 41.57% | $87.01M | $119.15M | $113.67M | -4.60% | 05/06/2020 | Get Alert |
Sarepta Therapeutics (SRPT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $1.90 | $1.90 | 0.00 % |
| Q3 | 2024-11-06 | $0.62 | $0.37 | 67.6 % |
| Q2 | 2024-08-07 | $0.44 | $0.02 | 2100.0 % |
| Q1 | 2024-05-01 | $0.73 | $-0.07 | 1142.9 % |
Sarepta Therapeutics (SRPT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-26 | $658.41M | $627.58M | 4.91 % |
| Q3 | 2024-11-06 | $467.17M | $409.30M | 14.1 % |
| Q2 | 2024-08-07 | $362.93M | $396.26M | -8.41 % |
| Q1 | 2024-05-01 | $413.46M | $373.28M | 10.8 % |
FAQ
When is Sarepta Therapeutics (NASDAQ:SRPT) reporting earnings?
Sarepta Therapeutics (SRPT) is scheduled to report earnings on April 30, 2025. The last reported earnings were for reported on February 26, 2025 for Q4.
What were the latest earnings per share (EPS) for Sarepta Therapeutics (NASDAQ:SRPT)?
The Actual EPS was $1.90, which hit the estimate of $1.90.
What were Sarepta Therapeutics’s (NASDAQ:SRPT) revenues?
The Actual Revenue was $658.4M, which beat the estimate of $627.6M.
Browse earnings estimates, EPS, and revenue on all stocks.